 |
 |
||||||
 |
Our customers' Feedback |
Your CART
$0.00 (0 items)
| |||||
Generic Repaglinide - Prandin
| ||||||
- FDA approved Tadalafil medication for the treatment of erectile dysfunction accompanied with primary and secondary symptoms of benign prostatic hyperplasia (BPH) in men above 45 years.
Considering the information of three randomized, multicenter, double, blind clinical studies and a retrospective analysis of the medical documentation, FDA approved on October 7, 2011 Tadalafil medication for the treatment of erectile dysfunction accompanied with primary and secondary symptoms of benign prostatic hyperplasia (BPH) in men above 45 years.
- The forming, development and monitoring of the pharmaceutical market in USA in September 2011
In spite of low rates and stagnation of industrial development, the pharmaceutical market shows a dynamical growth.
- Sildenafil citrate and pulmonary arterial hypertension
Pulmonary arterial hypertension Definition “pulmonary arterial hypertension” is related to a group of diseases characterized by: - Progressive increase in pulmonary vascular resistance; - Reduction in pulmonary bloodflow; - High pulmonary artery pressure; - Contractility of the heart right ventricle; - Right ventricular failure.
- Fruit and vegetables do not reduce overall cancer risk, review concludes
Eating lots of fruit and vegetables will do little to reduce your risk of developing cancer, according to a review of a decade of research involving more than a million people.
- Common painkillers could be linked to male reproductive disorder
The use of mild painkillers, such as paracetamol, in pregnancy – previously considered harmless to the baby in the womb – could be a major factor in the rise of male reproductive disorders, according to a study.
Toll FREE US Canada:
+1 800 532 4808
International:
+1 718 313 1498
+44 200 222 7084
MySecureBilling.com certified by:
- Health Ministry bans use of 'Pao Ni Kang' - New Straits Times
New Straits TimesHealth Ministry bans use of 'Pao Ni Kang'New Straits TimesPUTRAJAYA: The Drug Control Authority has cancelled the registration of a traditional product known as Pao Ni Kang because it was found to contain repaglinide, a scheduled poison.
- Victoza sales double as Novo Nordisk profits soar - Pharma Times
Victoza sales double as Novo Nordisk profits soarPharma TimesHowever, human insulins were down 7% to 2.
- 衛生總監：含諾和隆錠被撤銷註冊‧“公眾勿購買保胰康” - 星洲日報
衛生總監：含諾和隆錠被撤銷註冊‧“公眾勿購買保胰康”星洲日報（吉隆坡20日訊）衛生部提醒公眾不要購買和服用含有控製藥物“諾和隆錠”（repaglinide）的中藥保健品“保胰康”（Pao Ni Kang），因為“保胰康”已被藥品控制局撤銷註冊。 衛生總監拿督斯里哈山阿都拉曼今日發表文告指出，“諾和隆錠是用於治療糖尿病的控製藥物，被禁止使用於 .
- 中药保健品“保胰康”马国被禁 - 联合早报
中药保健品“保胰康”马国被禁联合早报（吉隆坡讯）马来西亚卫生部促请民众不要购买和服用含有管制药物“诺和隆锭”（repaglinide）的中药保健品“保胰康”（Pao Ni Kang），因为，药品控制局已撤消“保胰康”的注册。去年8月，新加坡卫生科学局已提醒公众，不要服用违 .
- “保胰康”含有毒成分 卫生部促公众避免服用 - 光华日报
“保胰康”含有毒成分 卫生部促公众避免服用光华日报（吉隆坡20日讯）随着药物控制局检验出“保胰康”传统药物含有瑞格列奈(repaglinide)有毒成分并撤销其药物注册后，卫生部促请公众避免服用这药物。 卫生总监拿督斯里哈山阿都拉曼说，上述药品由吉隆坡High Mean(马)私人 .
|
| Copyright 2010. HQDRUGS Ltd. 33 Drugs Pharmacy Network |